A comprehensive view of Pfizer Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

INTERNATIONAL PATENT: PFIZER INC. FILES APPLICATION FOR "METHOD OF TREATMENT OF CANCER PAIN WITH TANEZUMAB"

Executive Perspective: Pfizer CEO states 2023 pipeline may have the largest number of new product and indication launches they’ve ever had; Pfizer expects to introduce 19 new products or indications to the market in next 18 months

FDA to convene advisors to review experimental RSV vaccine candidate from Pfizer on February 28; group to meet in March to reviews RSV vaccine candidate from GSK

Australia Patent: Pfizer Files Application for 'Human cytomegalovirus gB polypeptide'

Australia: Pfizer Receives Patent for 'Streptococcus pneumoniae capsular polysaccharides and conjugates thereof'

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count